Signal Transduction And Targeted Therapy

Signal Transduction And Targeted Therapy杂志是一本国际顶尖期刊，是一本开放获取期刊。该杂志近三年影响因子分别为：2023年40.8、2022年39.3、2021年38.104。该杂志近三年CiteScore评价值分别为：2023年44.5、2022年31.5、2021年18.4。该刊专门致力于推进BIOCHEMISTRY & MOLECULAR BIOLOGY领域的研究，涵盖了BIOCHEMISTRY & MOLECULAR BIOLOGY领域的各个方面，汇集所有专家，促进BIOCHEMISTRY & MOLECULAR BIOLOGY领域的更好协作和信息共享。该期刊为BIOCHEMISTRY & MOLECULAR BIOLOGY领域的科研人员提供了一个高影响力的论坛，使该领域的科研人员、从业人员和学生能够接触到尖端的经验性调查分析、学术对话以及行业科研成果的最新发展。通过收录高质量的原创论文和评论论文，促进BIOCHEMISTRY & MOLECULAR BIOLOGY领域的应用与发展。该期刊还将该领域的创新与应用，以提高研究的质量和实用性。近年来在该刊上发文的国家和地区主要有：USA（发文量96）、Turkey（发文量2）、Taiwan（发文量1）、Switzerland（发文量1）、Sweden（发文量3）、Spain（发文量6）。

Signal Transduction And Targeted Therapy是一本由Springer Nature出版社发行的知名BIOCHEMISTRY & MOLECULAR BIOLOGY期刊。该杂志社联系方式CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW。审稿过程是确保期刊质量的关键环节。Signal Transduction And Targeted Therapy杂志的审稿速度平均需要 5 Weeks 。这一时间周期既体现了编辑部对稿件质量的严格把关，也反映了审稿专家对学术研究的尊重和支持。在这个过程中，作者们可以充分利用这段时间对自己的研究成果进行完善和优化，以提高论文的质量和影响力。如果您对该期刊感兴趣，并希望了解更多关于投稿流程、投稿要求和技巧的信息，您可以咨询本站的客服老师，我们将帮助您了解期刊的投稿要求、审稿流程以及可能遇到的问题，并根据您的具体情况提供相应的建议和解决方案。

Signal Transduction And Targeted Therapy杂志近期中国学者发表的论文主要有：

• 1、Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants Author: Wang, Qian; Yang, Chenchen; Yin, Li; Sun, Jing; Wang, Wei; Li, Hengchun; Zhang, Zhengyuan; Chen, Si; Liu, Bo; Liu, Zijian; Shi, Linjing; Liu, Xiaolin; Guan, Suhua; Wang, Chunhua; Qu, Linbing; Feng, Ying; Niu, Xuefeng; Feng, Liqiang; Zhao, Jincun; Li, Pingchao; Chen, Ling; Zhong, Nanshan
• 2、Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma Author: Hu, Junhui; Tan, Ping; Ishihara, Moe; Bayley, Nicholas A.; Schokrpur, Shiruyeh; Reynoso, Jeremy G.; Zhang, Yangjun; Lim, Raymond J.; Dumitras, Camelia; Yang, Lu; Dubinett, Steven M.; Jat, Parmjit S.; Van Snick, Jacques; Huang, Jiaoti; Chin, Arnold I.; Prins, Robert M.; Graeber, Thomas G.; Xu, Hua; Wu, Lily
• 3、Combination therapy with saxagliptin and vitamin D for the preservation of beta-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial Author: Yan, Xiang; Li, Xia; Liu, Bingwen; Huang, Jiaqi; Xiang, Yufei; Hu, Yuhang; Tang, Xiaohan; Zhang, Ziwei; Huang, Gan; Xie, Zhiguo; Zhou, Houde; Liu, Zhenqi; Wang, Xiangbing; Leslie, Richard David; Zhou, Zhiguang
• 4、Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions Author: Ma, Jun; Li, Yanan; Yang, Xiangyu; Liu, Kai; Zhang, Xin; Zuo, Xianghao; Ye, Runyu; Wang, Ziqiong; Shi, Rufeng; Meng, Qingtao; Chen, Xiaoping
• 5、RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis Author: Chen, Lei; Zhang, Wenjing; Chen, Dan; Yang, Quan; Sun, Siwen; Dai, Zhenwei; Li, Zhengzheng; Liang, Xuemei; Chen, Chaoqun; Jiao, Yuexia; Zhi, Lili; Zhao, Lianmei; Zhang, Jinrui; Liu, Xuefeng; Zhao, Jinyao; Li, Man; Wang, Yang; Qi, Yangfan
• 6、Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2 Author: Xu, Zhijian; Shi, Danrong; Han, Jian-Bao; Ling, Yun; Jiang, Xiangrui; Lu, Xiangyun; Li, Chuan; Gong, Likun; Ge, Guangbo; Zhang, Yani; Zang, Yi; Song, Tian-Zhang; Feng, Xiao-Li; Tian, Ren-Rong; Ji, Jia; Zhu, Miaojin; Wu, Nanping; Wu, Chunhui; Wang, Zhen; Xu, Yechun; Peng, Cheng; Zheng, Min; Yang, Junling; Du, Feifei; Wu, Junliang; Wang, Peipei; Shen, Jingshan; Zhang, Jianliang; Zheng, Yong-Tang; Yao, Hangping; Zhu, Weiliang